BOLT - Bolt Biotherapeutics, Inc.

QQQ $ 481.15 $ 6.24 (1.31 %)

DIA $ 409.09 $ 2.37 (0.58 %)

SPY $ 559.11 $ 5.30 (0.96 %)

TLT $ 97.90 $ 0.45 (0.46 %)

GLD $ 231.62 $ -0.38 (-0.16 %)

Previous Close

$ 0.691

Open

$ 0.69

Bid

$ 0.69 x 1,251

Ask

-- x --

Day's Range

$ 0.69 - $ 0.70

52 Week Range

$ 0.65 - $ 1.56

Volume

55,290

Average Volume

Market Cap

26.35M

Beta (5Y Monthly)

$ 0.89

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	03-21-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-07-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-29-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-10-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-30-2022	12-31-2021	10-K
12	11-09-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-31-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Neutral on ...
08/15/2024 09:52:29

HC Wainwright & Co. analyst Edward White reiterates Bolt Biotherapeutics (NASDAQ:BOLT) with a Neutral.

Bolt Biotherapeutics Q2 EPS $(0.56) Misses...
08/13/2024 20:38:32

Bolt Biotherapeutics (NASDAQ:BOLT) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate o...

why-bolt-biotherapeutics-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Bolt Biotherapeutics Shares Are Tradin...
05/15/2024 17:38:38

Leerink Partners Downgrades Bolt Biotherap...
05/15/2024 17:28:22

Leerink Partners analyst Daina Graybosch downgrades Bolt Biotherapeutics (NASDAQ:BOLT) from Outperform to Market Perform and...

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
05/15/2024 16:31:58

Jones Trading Downgrades Bolt Biotherapeut...
05/15/2024 16:11:32

Jones Trading analyst Soumit Roy downgrades Bolt Biotherapeutics (NASDAQ:BOLT) from Buy to Hold.

HC Wainwright & Co. Downgrades Bolt Biothe...
05/15/2024 16:05:36

HC Wainwright & Co. analyst Edward White downgrades Bolt Biotherapeutics (NASDAQ:BOLT) from Buy to Neutral.

This Accenture Analyst Is No Longer Bullis...
05/15/2024 12:24:23

why-arcutis-biotherapeutics-shares-are-trading-higher-by-29-here-are-20-stocks-moving-premarket

Why Arcutis Biotherapeutics Shares Are Tra...
05/15/2024 12:14:56

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
05/15/2024 12:06:56

Guggenheim Downgrades Bolt Biotherapeutics...
05/15/2024 10:27:58

Guggenheim analyst Michael Schmidt downgrades Bolt Biotherapeutics (NASDAQ:BOLT) from Buy to Neutral.

Stifel Downgrades Bolt Biotherapeutics to ...
05/15/2024 09:39:58

Stifel analyst Stephen Willey downgrades Bolt Biotherapeutics (NASDAQ:BOLT) from Buy to Hold and lowers the price target fro...

Bolt Biotherapeutics Q1 2024 GAAP EPS $(0....
05/14/2024 20:31:53

Bolt Biotherapeutics (NASDAQ:BOLT) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of ...

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 20:31:13

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
04/03/2024 20:31:20

HC Wainwright & Co. Maintains Buy on Bolt ...
03/22/2024 15:00:18

HC Wainwright & Co. analyst Edward White maintains Bolt Biotherapeutics (NASDAQ:BOLT) with a Buy and maintains $8 price ...

Bolt Biotherapeutics Q4 EPS $(0.47) Beats ...
03/21/2024 20:20:10

Bolt Biotherapeutics (NASDAQ:BOLT) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of ...

Bolt Biotherapeutics Enrolls First Patient...
12/05/2023 12:02:08

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the t...

Bolt Biotherapeutics Q3 EPS $(0.43) Beats ...
11/09/2023 22:23:19

Bolt Biotherapeutics (NASDAQ:BOLT) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of ...

Bolt Biotherapeutics Presents Updated Clin...
10/23/2023 14:32:49

Updated safety data supports the selection of 20 mg/kg q2w as the recommended Phase 2 dose (RP2D) Improved efficacy with one pa...